SuperworthKiniksa Pharmaceuticals International shares outstanding KNSA
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 83.4M
- On a year earlier
- +7.0%
- more shares
Kiniksa Pharmaceuticals International had 83.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 7.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 81.8M | +13% |
| FY2024 | 72.3M | +0% |
| FY2023 | 72.2M | +2% |
| FY2022 | 70.8M | +3% |
| FY2021 | 69M | +1% |
| FY2020 | 68.1M | +24% |
| FY2019 | 54.9M | +13% |
| FY2018 | 48.5M | +2093% |
| FY2017 | 2.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 83.4M | +7% | |
| Q1 FY26 | 82.4M | +8% | |
| Q4 FY25 | 81.8M | +13% | |
| Q3 FY25 | 80M | +12% | |
| Q2 FY25 | 77.9M | +10% | |
| Q1 FY25 | 76.1M | +8% | |
| Q4 FY24 | 72.3M | +0% | |
| Q3 FY24 | 71.7M | +2% | |
| Q2 FY24 | 71M | −1% | |
| Q1 FY24 | 70.6M | +1% | |
| Q4 FY23 | 72.2M | +2% | |
| Q3 FY23 | 70.2M | −1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Kiniksa Pharmaceuticals International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.